Neurologic syndromes related to anti-GAD65
Clinical and serologic response to treatment
Citation Manager Formats
Make Comment
See Comments
This article has a correction. Please see:

Article Information
- Received November 25, 2019
- Accepted in final form January 13, 2020
- First Published March 2, 2020.
Author Disclosures
- Amaia Muñoz-Lopetegi, MD,
- Marienke A.A.M. de Bruijn, MD,
- Sanae Boukhrissi, BSc,
- Anna E.M. Bastiaansen, MD,
- Mariska M.P. Nagtzaam, BSc,
- Esther S.P. Hulsenboom, BSc,
- Agnita J.W. Boon, MD, PhD,
- Rinze F. Neuteboom, MD, PhD,
- Juna M. de Vries, MD, PhD,
- Peter A.E. Sillevis Smitt, MD, PhD,
- Marco W.J. Schreurs, PhD and
- Maarten J. Titulaer, MD, PhD
- Amaia Muñoz-Lopetegi, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Marienke A.A.M. de Bruijn, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Sanae Boukhrissi, BSc,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Anna E.M. Bastiaansen, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Mariska M.P. Nagtzaam, BSc,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Esther S.P. Hulsenboom, BSc,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Agnita J.W. Boon, MD, PhD,
NONE
NONE
commercial non profit organisation, advisory board single session, subject apomorphin in Parkinson's Disease
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Rinze F. Neuteboom, MD, PhD,
Data safety monitory board: EXCEL study (neurofibromatosis) (non profit entity()
NONE
NONE
member editorial board european journal of paediatric neurology
NONE
NONE
NONE
Zogenix (profit entity)
NONE
NONE
NONE
NONE
NONE
NONE
MS research foundation
NONE
NONE
NONE
NONE
NONE
NONE
- Juna M. de Vries, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Peter A.E. Sillevis Smitt, MD, PhD,
NONE
NONE
NONE
NONE
P. Sillevis Smitt holds a patent for the detection of anti-DNER.
NONE
NONE
NONE
NONE
NONE
NONE
Peter Sillevis Smitt received a research grant from Euroimmun.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Marco W.J. Schreurs, PhD and
NONE
NONE
(1) Thermo Scientific, speaker honoraria(2) Biogen, speaker honoraria
(1) Nederlands tijdschrift voor Allergie & Astma, editorial advisory board member, 2015-
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Combined ophthalmic research, Rotterdam(2) Stichting de Merel, Den Haag(3) Stichting Blindenbelangen, Rotterdam(4) Stichting Lijf en Leven
NONE
NONE
NONE
NONE
NONE
NONE
- Maarten J. Titulaer, MD, PhD
NONE
NONE
NONE
(1) Neurology: Neuroimmunology & Neuroinflammation, since June 2014
(1) filed a patent for "methods for typing neurological disorders and cancer, and devices for use therein" specifically about diagnostics for anti-GABAB receptor antibodies and KCTD antibodies.
NONE
NONE
NONE
NONE
NONE
NONE
(1) Medimmune LLC, research funds for serving on the scientific advisory board; (2) Guidepoint Global LLC, research funds for consultancy; (3) Novartis, research funds for teaching; (4) unrestricted research grant from Euroimmun AG.
(1) supported by the Netherlands Organisation for Scientific Research (NWO, Veni incentive and Memorabel initiative)
(1) Previously supported by an ErasmusMC fellowship
(1) supported by the Dutch Epilepsy Foundations, projectnumbers 14-19 and 19-08.
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Neurology (A.M.-L., M.A.A.M.d.B., A.E.M.B., M.M.P.N., E.S.P.H., A.J.W.B., R.F.N., J.M.d.V., P.A.E.S.S., M.J.T.) and Department of Immunology (S.B., M.W.J.S.), Erasmus MC University Medical Center; Department of Neurology (A.M.-L.), IDIBAPS, Barcelona, Spain; and Health Care Provider of the European Reference Network on Immunodeficiency, Autoinflammatory and Autoimmune Diseases (ERN-RITA) (M.J.T.), Rotterdam, the Netherlands.
- Correspondence
Dr. Titulaer m.titulaer{at}erasmusmc.nl
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Babak Hooshmand and Dr. David Smith
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Editor's Corner
N2 year in reviewJosep Dalmau, Marinos C. Dalakas, Dennis L. Kolson et al.Neurology: Neuroimmunology & Neuroinflammation, December 18, 2020 -
Cases
Anti-GAD antibody syndrome with concomitant cerebellar ataxia, stiff person syndrome, and limbic encephalitisSara M. Schaefer, Jeremy J. Moeller et al.Neurology: Clinical Practice, June 04, 2015 -
Editor's Corner
The tip of antibody-testing iceberget al.Neurology: Neuroimmunology & Neuroinflammation, April 10, 2020 -
Article
Thymoma and Autoimmune EncephalitisClinical Manifestations and AntibodiesMar Guasp, Jon Landa, Eugenia Martinez-Hernandez et al.Neurology: Neuroimmunology & Neuroinflammation, July 23, 2021